Associated Papers
Cystic fibrosis risk variants confer protection against inflammatory bowel disease.
Yu M et al.
Cell Genomics, 2025
41330381 (PubMed )
Supplement: mmc3.xlsx › Sheet1
Cystic fibrosis risk variants confer protection against inflammatory bowel disease.
Yu M et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
39677473 (PubMed )
Supplement: media-1.xlsx › ST3
Changes in the R-region interactions depend on phosphorylation and contribute to PKA and PKC regulation of the cystic fibrosis transmembrane conductance regulator chloride channel.
Poroca DR et al.
Faseb Bioadvances, 2020
Role of tyrosine phosphorylation in the muscarinic activation of the cystic fibrosis transmembrane conductance regulator (CFTR).
Billet A et al.
The Journal of Biological Chemistry, 2013
PKC phosphorylation modulates PKA-dependent binding of the R domain to other domains of CFTR.
Seavilleklein G et al.
American Journal of Physiology. Cell Physiology, 2008
Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator.
Chappe V et al.
Proceedings of the National Academy of Sciences of the United States of America, 2004
Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA.
Chappe V et al.
The Journal of Physiology, 2003
Select a paper to view details